» Articles » PMID: 39337636

Involvement of Intestinal Epithelium Aryl Hydrocarbon Receptor Expression and 3, 3'-Diindolylmethane in Colonic Tertiary Lymphoid Tissue Formation

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Sep 28
PMID 39337636
Authors
Affiliations
Soon will be listed here.
Abstract

Tertiary lymphoid tissues (TLTs) are adaptive immune structures that develop during chronic inflammation and may worsen or lessen disease outcomes in a context-specific manner. Immune cell activity governing TLT formation in the intestines is dependent on immune cell aryl hydrocarbon receptor (AhR) activation. Homeostatic immune cell activity in the intestines is further dependent on ligand activation of AhR in intestinal epithelial cells (IECs), yet whether AhR activation and signaling in IECs influences the formation of TLTs in the presence of dietary AhR ligands is not known. To this end, we used IEC-specific AhR deletion coupled with a mouse model of dextran sodium sulfate (DSS)-induced colitis to understand how dietary AhR ligand 3, 3'-diindolylmethane (DIM) influenced TLT formation. DIM consumption increased the size of TLTs and decreased T-cell aggregation to TLT sites in an IEC-specific manner. In DSS-exposed female mice, DIM consumption increased the expression of genes implicated in TLT formation (Interleukin-22, ; CXC motif chemokine ligand 13, ) in an IEC AhR-specific manner. Conversely, in female mice without DSS exposure, DIM significantly reduced the expression of or in iAhRKO mice, but this effect was not observed in WT animals. Our findings suggest that DIM affects the immunological landscape of TLT formation during DSS-induced colitis in a manner contingent on AhR expression in IECs and biological sex. Further investigations into specific immune cell activity, IEC-specific AhR signaling pathways, and dietary AhR ligand-mediated effects on TLT formation are warranted.

References
1.
Chassaing B, Srinivasan G, Delgado M, Young A, Gewirtz A, Vijay-Kumar M . Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012; 7(9):e44328. PMC: 3434182. DOI: 10.1371/journal.pone.0044328. View

2.
Stallhofer J, Friedrich M, Konrad-Zerna A, Wetzke M, Lohse P, Glas J . Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status. Inflamm Bowel Dis. 2015; 21(10):2327-40. DOI: 10.1097/MIB.0000000000000515. View

3.
Dodd K, Menon M . Sex bias in lymphocytes: Implications for autoimmune diseases. Front Immunol. 2022; 13:945762. PMC: 9730535. DOI: 10.3389/fimmu.2022.945762. View

4.
Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A . Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res. 2014; 20(8):2147-58. DOI: 10.1158/1078-0432.CCR-13-2590. View

5.
Aden K, Breuer A, Rehman A, Geese H, Tran F, Sommer J . Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair. Oncogenesis. 2016; 5(11):e270. PMC: 5141292. DOI: 10.1038/oncsis.2016.71. View